Amlodipine Besylate Tablet
Product Images NDC 69584-021

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 69584-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oxford Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg Label

This is a medication description for a tablet of Amlodipine Besylate. The medication is manufactured by Oot Pharmaceutical located in Birmingham, Alabama. The medication is prescribed by a pharmacist and must be dispensed with a patient information sheet. The last dosage revision for this medication was on January 27th, 2021. The medication should be taken orally. The text also includes various codes and contact information for the manufacturer.*

FDA Label Image

2.5mg Label

This is a description of a medication called Amlodipine Besylate. It comes in tablet form and is manufactured by a company called Semmgan Advamediztt. The medication is only available with a prescription from a pharmacist and comes in bottles containing 1000 tablets. The packaging contains a serialization area and instructions on how to print a patient information sheet by visiting a website called pswwadions mcomimed-gues. The manufacturer appears to be Oxford Pharmaceuticals LLC.*

FDA Label Image

5mg Label

This appears to be a medication label for Amlodipine Besylate tablets, with the National Drug Code (NDC) 69584-022. The label includes dosage information and instructions for pharmacists to dispense the medication with a patient information sheet, which can be printed from a website provided. The label is associated with Oxford Pharmaceuticals, LLC.*

FDA Label Image

Figure-1 (Figure1)

This appears to be a statistical output of a survival analysis involving a treatment (Amlodipine) and a control group (Placebo). The output includes the Event Rate, P-value, Hazard Ratio, and Confidence Interval. Additionally, there is a graph that charts time (in months) and the number at risk. This output is likely part of a larger analysis that aims to compare the effectiveness of Amlodipine versus the Placebo.*

FDA Label Image

Figure-2 (Figure2)

This is a table showing the demographics and baseline characteristics of patients in a study. It includes information on age, gender, baseline blood pressure, vessel disease, vessel stenosis, and types of treatments received. The number of participants is also noted for each category. There is a section at the bottom with an unclear title and two values, "Favors Amlodipine" and "Favors Placebo," with a "Hazard Ratio" listed but no explanation is given for these values.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.